Manufacturing
Latest News
Advertisement
Advertisement
Advertisement
Advertisement
The evolution of therapeutic modalities drives the adoption of single-use technologies.

Despite a growing number of biosimilar approvals, market uptake remains a challenge.

Given the criticality of fill/finish processes, it is clear that automation is the next technological step.

